NCT03543800View on ClinicalTrials.gov

PRP Treatment of Osteoarthritic Knee With a New Autologous Blood Product (CytoRich)

NAUnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 4, 2015

Primary Completion Date

May 20, 2019

Study Completion Date

May 20, 2019

Conditions
Osteoarthritis of the Knee
Interventions
DEVICE

Cytorich PRP kit

Subjects randomized to the PRP treatment arm will receive PRP only without the anti-inflammatory component of ABP added

DEVICE

PRP kit

PRP kit legally marketed in Canada for PRP

Trial Locations (1)

M8W 3T4

Galea Clinic, Etobicoke

Sponsors

Lead Sponsor

Antnor
All Listed Sponsors
lead

Antnor

INDUSTRY

NCT03543800 - PRP Treatment of Osteoarthritic Knee With a New Autologous Blood Product (CytoRich) | Biotech Hunter | Biotech Hunter